ARCHIVES

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

This article is from The Cancer Letter archive.

Vol. 20 No. 25 | June 24, 1994

Download PDF Visit The Full Archive

Related Articles

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

Treatment Progress Since 1972 Provides Powerful Support For Continuing National Cancer Program

March 23, 1979

FCRC Decision Due In 90 Days, Upton Says

November 24, 1978

Five Investigations Probe NIH Radiation Contamination

November 17, 1995

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007